ConductScience.org, home

Paper8943365

Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.

Devergne O and 6 others. Mol Cell Biol, 1996. Cited by 427 papers, by iCite.

Cite this record

ConductScience Library. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Papers, record 8943365. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8943365

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
PubMed
Journal
Mol Cell Biol
PubMed
Year
1996
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
427
iCite
Relative citation ratio, by iCite
8.42
iCite
Revised in PubMed
2021-05-26
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Devergne OO
2Hatzivassiliou EE
3Izumi KMK M
4Kaye KMK M
5Kleijnen MFM F
6Kieff EE
7Mosialos GG

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Herpesvirus 4, HumanMajor topic
ProteinsMajor topic
Viral Matrix ProteinsMajor topic
B-Lymphocytes
Cell Transformation, Viral
Gene Expression Regulation
Humans
NF-kappa B
TNF Receptor-Associated Factor 1
TNF Receptor-Associated Factor 2
TNF Receptor-Associated Factor 3
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA01568-04NCI NIH HHSUnited StatesPubMedPubMed
CA47006NCI NIH HHSUnited StatesR01CA047006PubMed and NIHNIH RePORTER
CA67380-02NCI NIH HHSUnited StatesPubMedPubMed
K11CA001568NIHNIH RePORTER
R01CA067380NIHNIH RePORTER
R35CA047006NIHNIH RePORTER

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18552191Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes.Nature1996https://conductscience.org/library/papers/8552191PubMed
28551575A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes.J Virol1996https://conductscience.org/library/papers/8551575PubMed
38627180T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors.J Exp Med1996https://conductscience.org/library/papers/8627180PubMed
48608943TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation.Genes Dev1996https://conductscience.org/library/papers/8608943PubMed
58855313Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8855313PubMed
68892903Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1.J Virol1996https://conductscience.org/library/papers/8892903PubMed
74705382A new technique for the assay of infectivity of human adenovirus 5 DNA.Virology1973https://conductscience.org/library/papers/4705382PubMed
86086953Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.J Virol1984https://conductscience.org/library/papers/6086953PubMed
96095274A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6095274PubMed
102991591Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.J Virol1985https://conductscience.org/library/papers/2991591PubMed
113005654Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus.J Virol1986https://conductscience.org/library/papers/3005654PubMed
123047011Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.Gene1988https://conductscience.org/library/papers/3047011PubMed
132845129Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.J Virol1988https://conductscience.org/library/papers/2845129PubMed
142157887Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.J Virol1990https://conductscience.org/library/papers/2157887PubMed
151698631Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40.Eur J Immunol1990https://conductscience.org/library/papers/1698631PubMed
161648447Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.Cell1991https://conductscience.org/library/papers/1648447PubMed
171318423Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells.J Virol1992https://conductscience.org/library/papers/1318423PubMed
188382256Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.J Exp Med1993https://conductscience.org/library/papers/8382256PubMed
198415670Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8415670PubMed
208207810
Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation.
J Virol1994https://conductscience.org/library/papers/8207810PubMed

See all 35 referencesDownload CSV of references

Cited by197

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 427 citations.

PMIDTitleJournalYearIn PapersSource
42595846A role for the protease MALT1 in EBV-mediated B-cell transformation by Latent Membrane Proteins 1 and 2.Leukemia2026https://conductscience.org/library/papers/42595846PubMed
42524018The role of Epstein-Barr virus in NK/T cell lymphoproliferative disorders: molecular mechanisms and potential therapeutic strategies.Front Immunol2026https://conductscience.org/library/papers/42524018PubMed
41959453Epstein-Barr Virus Latent Membrane Protein 1 Suppresses Ferroptosis via Pentose Phosphate Pathway and Glutathione Metabolism.bioRxiv2026https://conductscience.org/library/papers/41959453PubMed
41959378CRISPR Screens Reveal Epstein-Barr Virus-activated JunB as a Key Lymphoblastoid B cell Dependency Factor that Represses Cyclin Dependent Kinase Inhibitor P18INK4c.bioRxiv2026https://conductscience.org/library/papers/41959378PubMed
41587214Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-κB pathway.PLoS Pathog2026https://conductscience.org/library/papers/41587214PubMed
41445616Host Genetic Architecture between Epstein-Barr Virus Activity and Multiple Sclerosis Reveals Shared Pathways.medRxiv2025https://conductscience.org/library/papers/41445616PubMed
40953326Epstein-Barr Virus in Multiple Sclerosis: Past, Present, and Future.Neurol Neuroimmunol Neuroinflamm2025https://conductscience.org/library/papers/40953326PubMed
40950096Epstein-Barr Virus Latent Membrane Protein 1 targets cIAP1, cIAP2 and TRAF2 for Proteasomal Degradation to Activate the Non-canonical NF-κB Pathway.bioRxiv2025https://conductscience.org/library/papers/40950096PubMed
39817754Multiple sclerosis and infection: history, EBV, and the search for mechanism.Microbiol Mol Biol Rev2025https://conductscience.org/library/papers/39817754PubMed
39769218Epstein-Barr Virus BRRF1 Induces Butyrophilin 2A1 in Nasopharyngeal Carcinoma NPC43 Cells via the IL-22/JAK3-STAT3 Pathway.Int J Mol Sci2024https://conductscience.org/library/papers/39769218PubMed
39402748Targeting the LMP1-ALIX axis in EBV+ nasopharyngeal carcinoma inhibits immunosuppressive small extracellular vesicle secretion and boosts anti-tumor immunity.Cancer Commun (Lond)2024https://conductscience.org/library/papers/39402748PubMed
39141346Polyomavirus ALTOs, but not MTs, downregulate viral early gene expression by activating the NF-κB pathway.Proc Natl Acad Sci U S A2024https://conductscience.org/library/papers/39141346PubMed
38826197Polyomavirus ALTOs, but not MTs, downregulate viral early gene expression by activating the NF-κB pathway.bioRxiv2024https://conductscience.org/library/papers/38826197PubMed
38195569Epstein-Barr virus-driven B cell lymphoma mediated by a direct LMP1-TRAF6 complex.Nat Commun2024https://conductscience.org/library/papers/38195569PubMed
38136637Role of Virus-Induced EGFR Trafficking in Proviral Functions.Biomolecules2023https://conductscience.org/library/papers/38136637PubMed
37561629Epstein-Barr virus evades restrictive host chromatin closure by subverting B cell activation and germinal center regulatory loci.Cell Rep2023https://conductscience.org/library/papers/37561629PubMed
37503344Evidence for a causal relationship between psoriasis and cutaneous melanoma: a bidirectional two-sample Mendelian randomized study.Front Immunol2023https://conductscience.org/library/papers/37503344PubMed
36960148Adoptive T-cell therapy targeting Epstein-Barr virus as a treatment for multiple sclerosis.Clin Transl Immunology2023https://conductscience.org/library/papers/36960148PubMed
36814922TRAF3: Guardian of T lymphocyte functions.Front Immunol2023https://conductscience.org/library/papers/36814922PubMed
36267276Role of CD40(L)-TRAF signaling in inflammation and resolution-a double-edged sword.Front Pharmacol2022https://conductscience.org/library/papers/36267276PubMed

See all 197 cited byDownload CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD40958PubTator's text mininghttps://conductscience.org/library/genes/958NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
TNFRSF1A7132PubTator's text mininghttps://conductscience.org/library/genes/7132NCBI Gene
TNFRSF8943PubTator's text mininghttps://conductscience.org/library/genes/943NCBI Gene
TRAF17185PubTator's text mininghttps://conductscience.org/library/genes/7185NCBI Gene
TRAF27186PubTator's text mininghttps://conductscience.org/library/genes/7186NCBI Gene
TRAF37187PubTator's text mininghttps://conductscience.org/library/genes/7187NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8943365

GET https://conductscience.org/api/papers/v1/8943365/references?page=2